Valuation : Arcoma AB

Market Cap 118M 12.39M 10.64M 9.96M 9.12M 17.18M 1.18B 17.22M 46.09M 596M 46.52M 45.51M 1.97B P/E 2024
12.7x
P/E 2025 20.9x
Enterprise Value 82.68M 8.69M 7.46M 6.98M 6.39M 12.04M 830M 12.08M 32.32M 418M 32.62M 31.91M 1.38B EV / Sales 2024
0.82x
EV / Sales 2025 0.53x
Free-Float
57.91%
Yield 2024 *
-
Yield 2025 -
1 day+1.73%
1 week+2.23%
Current month-8.24%
1 month-0.48%
3 months-15.92%
6 months+4.04%
Current year+12.26%
1 week 7.38
Extreme 7.38
8.68
1 month 7.38
Extreme 7.38
9.6
Current year 6.16
Extreme 6.16
10.05
1 year 6.16
Extreme 6.16
10.05
3 years 6.16
Extreme 6.16
18.3
5 years 6.16
Extreme 6.16
18.9
10 years 3.57
Extreme 3.57
26.3
Manager TitleAgeSince
Chief Executive Officer 45 2022-12-31
Chief Tech/Sci/R&D Officer - 2026-05-31
Chief Operating Officer 38 2024-12-31
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Chairman 54 2016-12-31
Director/Board Member 59 2021-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.73%+2.23%-2.83%+10.60% 12.16M
+1.30%-2.20%-21.41%+2.27% 12.86B
-0.14%-3.28%+20.78%+10.23% 4.51B
-0.21%-6.01%-44.16%-55.99% 1.23B
+2.96%-1.50%-37.93%-35.37% 1.16B
-0.54%+0.37%+17.81%+83.84% 1.12B
+3.30%-6.69%-41.06% - 1.05B
-0.32%-6.73%+40.23%+122.08% 525M
+4.12%+2.54%+53.03% - 291M
+0.08%-9.10%-66.75%+292.67% 246M
Average +1.23%-1.96%-8.23%+53.79% 2.3B
Weighted average by Cap. +1.01%-1.48%-12.31%+9.02%

Financials

2024 2025
Net sales 157M 16.48M 14.14M 13.24M 12.13M 22.84M 1.57B 22.91M 61.3M 793M 61.87M 60.53M 2.63B 131M 13.74M 11.8M 11.05M 10.11M 19.05M 1.31B 19.11M 51.13M 662M 51.6M 50.49M 2.19B
Net income 11.18M 1.17M 1.01M 944K 864K 1.63M 112M 1.63M 4.37M 56.54M 4.41M 4.32M 187M 5.03M 529K 454K 425K 389K 733K 50.48M 735K 1.97M 25.44M 1.98M 1.94M 84.2M
Net Debt -13.32M -1.4M -1.2M -1.12M -1.03M -1.94M -134M -1.95M -5.21M -67.36M -5.25M -5.14M -223M -35.23M -3.7M -3.18M -2.97M -2.72M -5.13M -354M -5.15M -13.77M -178M -13.9M -13.6M -590M
Logo Arcoma AB
Arcoma AB is a Sweden-based medical technology company. It develops, produces and markets digital radiographic systems. Its products offer digital imaging technology combined with advanced mobile positioning system. The Company's product portfolio comprises: complete radiographic systems available as ceiling suspensions and floor mounted systems, as well as detectors; radiographic system components, such as overhead tube crane, cube, tilting wall stand and radiographic tables; and mobile imaging tables in two series, namely Precision and Elite. Its products are designed for hospitals, clinics, imaging centers and private practices, and available through three market channels: its own brand IMIX, private label distributors and original equipment manufacturers (OEM).
Employees
31
Date Price Change Volume
26-08-27 SEK 8.240 +1.73% 3,233
26-08-26 SEK 8.100 -1.94% 18,590
26-08-25 SEK 8.260 +2.23% 9,718
26-08-24 SEK 8.080 -0.25% 2,438
26-08-21 SEK 8.100 -4.48% 33,140

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ARCOMA Stock